| Abstrakt: |
Keywords: Biological Factors; Biomarkers; Cancer; Chemoprevention; Clinical Trials and Studies; Diagnostics and Screening; Drugs and Therapies; Health and Medicine; Iloprost; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology; Pre-Trial Research; Risk and Prevention; Synthetic Prostaglandins EN Biological Factors Biomarkers Cancer Chemoprevention Clinical Trials and Studies Diagnostics and Screening Drugs and Therapies Health and Medicine Iloprost Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology Pre-Trial Research Risk and Prevention Synthetic Prostaglandins 785 785 1 03/27/23 20230328 NES 230328 2023 MAR 28 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Investigators discuss new findings in non-small cell lung cancer. According to news reporting out of Aurora, Colorado, by NewsRx editors, research stated, "Lung cancer chemoprevention is critical to addressing cancer burden in high-risk populations.". [Extracted from the article] |
